Immunohistochemistry also revealed significantly larger subsets of human CD8+ cells in the BM of mice treated with Tri-T cell infusion, compared with untreated mice (Figure 5E), suggesting the effective elimination of human AML blasts by Tri-T cells in vivo. The gene discussed is CD8A; the disease is acute myeloid leukemia.